{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:04:01Z","timestamp":1792785841466,"version":"4.5.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"US Office of Division of AIDS"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DAA2-16-62066-1"],"award-info":[{"award-number":["DAA2-16-62066-1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1HD058971"],"award-info":[{"award-number":["RO1HD058971"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>An accurate point-of-care test for tuberculosis (TB) in children remains an elusive goal. Recent evaluation of a novel point-of-care urinary lipoarabinomannan test, Fujifilm SILVAMP Tuberculosis Lipoarabinomannan (FujiLAM), in adults living with human immunodeficiency virus (HIV) showed significantly superior sensitivity than the current Alere Determine Tuberculosis Lipoarabinomannan test (AlereLAM). We therefore compared the accuracy of FujiLAM and AlereLAM in children with suspected TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Children hospitalized with suspected TB in Cape Town, South Africa, were enrolled (consecutive admissions plus enrichment for a group of children living with HIV and with TB), their urine was collected and biobanked, and their sputum was tested with mycobacterial culture and Xpert MTB\/RIF or Xpert MTB\/RIF Ultra. Biobanked urine was subsequently batch tested with FujiLAM and AlereLAM. Children were categorized as having microbiologically confirmed TB, unconfirmed TB (clinically diagnosed), or unlikely TB.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 204 children were enrolled and had valid results from both index tests, as well as sputum microbiological testing. Compared to a microbiological reference standard, the sensitivity of FujiLAM and AlereLAM was similar (42% and 50%, respectively), but lower than that of Xpert MTB\/RIF of sputum (74%). The sensitivity of FujiLAM was higher in children living with HIV (60%) and malnourished children (62%). The specificity of FujiLAM was substantially higher than that of AlereLAM (92% vs 66%, respectively). The specificity of both tests was higher in children 2 years or older (FujiLAM, 96%; AlereLAM, 72%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The high specificity of FujiLAM suggests utility as a \u201crule-in\u201d test for children with a high pretest probability of TB, including hospitalized children living with HIV or with malnutrition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/cid\/ciaa1052","type":"journal-article","created":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T15:28:59Z","timestamp":1596554939000},"page":"e280-e288","source":"Crossref","is-referenced-by-count":50,"title":["Accuracy of a Novel Urine Test, Fujifilm SILVAMP Tuberculosis Lipoarabinomannan, for the Diagnosis of Pulmonary Tuberculosis in Children"],"prefix":"10.1093","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1366-4805","authenticated-orcid":false,"given":"Mark P","family":"Nicol","sequence":"first","affiliation":[{"name":"Division of Infection and Immunity, School of Biomedical Sciences, University of Western Australia, Perth, Australia"},{"name":"Division of Medical Microbiology and Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel G","family":"Schumacher","sequence":"additional","affiliation":[{"name":"Foundation for Innovative New Diagnostics, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Workman","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health and South African Medical Research Council Unit on Child and Adolescent Health, University of Cape Town and Red Cross War Memorial Children\u2019s Hospital, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Broger","sequence":"additional","affiliation":[{"name":"Foundation for Innovative New Diagnostics, Geneva, Switzerland"},{"name":"Division of Tropical Medicine, Centre of Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Baard","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health and South African Medical Research Council Unit on Child and Adolescent Health, University of Cape Town and Red Cross War Memorial Children\u2019s Hospital, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaretha","family":"Prins","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health and South African Medical Research Council Unit on Child and Adolescent Health, University of Cape Town and Red Cross War Memorial Children\u2019s Hospital, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindy","family":"Bateman","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health and South African Medical Research Council Unit on Child and Adolescent Health, University of Cape Town and Red Cross War Memorial Children\u2019s Hospital, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elloise","family":"du Toit","sequence":"additional","affiliation":[{"name":"Division of Medical Microbiology and Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judi","family":"van Heerden","sequence":"additional","affiliation":[{"name":"Division of Medical Microbiology and Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Szekely","sequence":"additional","affiliation":[{"name":"Foundation for Innovative New Diagnostics, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J","family":"Zar","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Child Health and South African Medical Research Council Unit on Child and Adolescent Health, University of Cape Town and Red Cross War Memorial Children\u2019s Hospital, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M","family":"Denkinger","sequence":"additional","affiliation":[{"name":"Foundation for Innovative New Diagnostics, Geneva, Switzerland"},{"name":"Division of Tropical Medicine, Centre of Infectious Diseases, University Hospital Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"key":"2021050500304769200_CIT0001","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(11)70167-0","article-title":"Accuracy of the Xpert MTB\/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study","volume":"11","author":"Nicol","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2021050500304769200_CIT0002","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1097\/INF.0000000000001960","article-title":"Accuracy of Xpert MTB\/RIF Ultra for the diagnosis of pulmonary tuberculosis in Children","volume":"37","author":"Nicol","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"2021050500304769200_CIT0003","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S2213-2600(15)00095-8","article-title":"Xpert MTB\/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis","volume":"3","author":"Detjen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"2021050500304769200_CIT0004","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(18)31267-4","article-title":"Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial","volume":"392","author":"Gupta-Wright","year":"2018","journal-title":"Lancet"},{"key":"2021050500304769200_CIT0005","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(15)01092-2","article-title":"Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial","volume":"387","author":"Peter","year":"2016","journal-title":"Lancet"},{"key":"2021050500304769200_CIT0006","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12916-017-0822-8","article-title":"Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort","volume":"15","author":"Lawn","year":"2017","journal-title":"BMC Med"},{"key":"2021050500304769200_CIT0007","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1016\/S2214-109X(14)70195-0","article-title":"Urine lipoarabinomannan testing for the diagnosis of pulmonary tuberculosis in children \u2013 a prospective study","volume":"2","author":"Nicol","year":"2014","journal-title":"Lancet Global Health"},{"key":"2021050500304769200_CIT0008","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1183\/09031936.00003315","article-title":"Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania","volume":"46","author":"Kroidl","year":"2015","journal-title":"Eur Respir J"},{"key":"2021050500304769200_CIT0009","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/QAD.0000000000001662","article-title":"Stool Xpert MTB\/RIF and urine lipoarabinomannan for the diagnosis of tuberculosis in hospitalized HIV-infected children","volume":"32","author":"LaCourse","year":"2018","journal-title":"AIDS"},{"key":"2021050500304769200_CIT0010","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3109\/00365548.2013.853133","article-title":"Reasons for false-positive lipoarabinomannan ELISA results in a Tanzanian population","volume":"46","author":"Kroidl","year":"2014","journal-title":"Scand J Infect Dis"},{"key":"2021050500304769200_CIT0011","doi-asserted-by":"crossref","first-page":"e01338","DOI":"10.1128\/JCM.01338-18","article-title":"A novel sensitive immunoassay targeting the 5-methylthio-d-xylofuranose-lipoarabinomannan epitope meets the WHO\u2019s performance target for tuberculosis diagnosis","volume":"56","author":"Sigal","year":"2018","journal-title":"J Clin Microbiol"},{"key":"2021050500304769200_CIT0012","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S1473-3099(19)30001-5","article-title":"Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study","volume":"19","author":"Broger","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2021050500304769200_CIT0013","doi-asserted-by":"crossref","first-page":"e1003113","DOI":"10.1371\/journal.pmed.1003113","article-title":"Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: a meta-analysis of individual in- and outpatient data","volume":"17","author":"Broger","year":"2020","journal-title":"PLoS Med"},{"key":"2021050500304769200_CIT0014"},{"key":"2021050500304769200_CIT0015","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1093\/cid\/civ581","article-title":"Clinical case definitions for classification of intrathoracic tuberculosis in children: an update","volume":"61","author":"Graham","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021050500304769200_CIT0016","doi-asserted-by":"crossref","first-page":"1\u201311","DOI":"10.1093\/ofid\/ofz530","article-title":"Diagnostic accuracy of a novel and rapid lipoarabinomannan test for diagnosing tuberculosis among people with human immunodeficiency virus","volume":"7","author":"Bjerrum","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2021050500304769200_CIT0017","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1473-3099(19)30684-X","article-title":"Tuberculosis test results using fresh versus biobanked urine samples with FujiLAM","volume":"20","author":"Broger","year":"2020","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1052\/33801012\/ciaa1052.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/9\/e280\/37792886\/ciaa1052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/72\/9\/e280\/37792886\/ciaa1052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T20:40:54Z","timestamp":1620160854000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/72\/9\/e280\/5881994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":17,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,8,6]]},"published-print":{"date-parts":[[2021,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1052","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2020,8,6]]}}}